Fibrinolytic capacity and risk of myocardial infarction

被引：8

作者：

vanderBom, JG

Bots, ML

Haverkate, F

Grobbee, DE

Kluft, C

机构：

[1] ERASMUS UNIV ROTTERDAM,SCH MED,NETHERLANDS INST HLTH SCI,NL-3000 DR ROTTERDAM,NETHERLANDS

[2] TNO,GAUBIUS LAB,PG,LEIDEN,NETHERLANDS

来源：

FIBRINOLYSIS | 1996年 / 10卷

关键词：

D O I：

10.1016/S0268-9499(96)80035-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9 / 12

页数：4

共 25 条

[1] THE LEVEL OF EXTRINSIC PLASMINOGEN-ACTIVATOR (T-PA) DURING CLOTTING AS A DETERMINANT OF THE RATE OF FIBRINOLYSIS - INEFFICIENCY OF ACTIVATORS ADDED AFTERWARDS
BROMMER, EJP
[J]. THROMBOSIS RESEARCH, 1984, 34 (02) : 109 - 115
[2] DOOIJEWAARD G, 1995, FIBRINOLYSIS DIS MAL, P233
[3] EMEIS JJ, 1988, TISSUE TYPE PLASMINO, P21
[4] ALLELE-SPECIFIC INCREASE IN BASAL TRANSCRIPTION OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE IS ASSOCIATED WITH MYOCARDIAL-INFARCTION
ERIKSSON, P
KALLIN, B
VANTHOOFT, FM
BAVENHOLM, P
HAMSTEN, A
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (06) : 1851 - 1855
[5] CROSS-LINKED FIBRIN DEGRADATION PRODUCTS, PROGRESSION OF PERIPHERAL ARTERIAL-DISEASE, AND RISK OF CORONARY HEART-DISEASE
FOWKES, FGR
LOWE, GDO
HOUSLEY, E
RATTRAY, A
RUMLEY, A
ELTON, RA
MACGREGOR, IR
DAWES, J
[J]. LANCET, 1993, 342 (8863) : 84 - 86
[6] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH CORONARY-ARTERY DISEASE - RELATIONS TO CLINICAL-VARIABLES AND CARDIOVASCULAR RISK-FACTORS
GEPPERT, A
BECKMANN, R
GRAF, S
HORNYKEWYCZ, S
LANG, I
SCHUSTER, E
BINDER, BR
HUBER, K
[J]. FIBRINOLYSIS, 1995, 9 : 109 - 113
[7] GRAM J, 1987, THROMB HAEMOSTASIS, V57, P137
[8] GRAM J, 1987, ACTA MED SCAND, V221, P149
[9] HAMSTEN A, 1987, LANCET, V4, P3
[10] PREDICTIVE VALUE OF TISSUE-PLASMINOGEN ACTIVATOR MASS CONCENTRATION ON LONG-TERM MORTALITY IN PATIENTS WITH CORONARY-ARTERY DISEASE - A 7-YEAR FOLLOW-UP
JANSSON, JH
OLOFSSON, BO
NILSSON, TK
[J]. CIRCULATION, 1993, 88 (05) : 2030 - 2034

← 1 2 3 →